| |
HER2
|
P53
|
Ki67
|
|---|
| |
Positive/total (percentage)
|
P
|
Positive/total (percentage)
|
P
|
Positive/total (percentage)
|
P
|
|---|
|
Total
|
9/73 (12.3)
| |
16/73 (21.9)
| |
26/73 (35.6)
| |
|
Tumour size (cm)
|
|
<2.0
|
4/20 (20.0)
|
0.41
|
5/20 (25.0)
|
0.94
|
7/20 (35.0)
|
>0.99
|
|
≥2.0
|
5/53 (9.4)
| |
11/53 (20.8)
| |
19/53 (35.8)
| |
|
Number of positive lymph nodes
|
|
0
|
1/22 (4.5)
|
0.34
|
3/22 (12.6)
|
0.41
|
6/22 (27.2)
|
0.47
|
|
≥1
|
8/51 (15.7)
| |
13/51 (25.5)
| |
20/51 (39.2)
| |
|
Histological grade
|
|
1
|
0/12 (0)
|
0.36
|
0/12 (0)
|
0.05
|
3/12 (25.0)
|
0.18
|
|
2
|
6/42 (14.3)
| |
9/42 (21.4)
| |
13/42 (31.0)
| |
|
3
|
3/19 (15.8)
| |
7/19 (36.8)
| |
10/19 (52.6)
| |
|
Estrogen receptor-α
|
|
Negative
|
4/17 (23.5)
|
0.23
|
5/17 (29.4)
|
0.60
|
8/17 (47.1)
|
0.40
|
|
Positive
|
5/56 (8.9)
| |
11/56 (19.6)
| |
18/56 (32.1)
| |
|
Progesterone receptor
|
|
Negative
|
3/18 (16.7)
|
0.81
|
5/18 (27.8)
|
0.71
|
9/18 (50.0)
|
0.23
|
|
Positive
|
6/55 (10.9)
| |
11/55 (20.0)
| |
17/55 (30.9)
| |
